| Literature DB >> 21267730 |
Abstract
Methotrexate (MTX) is a safe and well-tolerated drug for the treatment of rheumatic diseases, even if the strictest safety standards are considered. Initial apprehension as to severe pulmonary or hepatic side-effects has not been confirmed. The risk of infection is not elevated compared with other disease-modifying antirheumatic drugs. In addition, a mutagenic potential could not be demonstrated even after long-term application. Therefore, MTX will maintain its significant role in antirheumatic therapy also in the near future.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21267730 DOI: 10.1007/s00393-010-0687-0
Source DB: PubMed Journal: Z Rheumatol ISSN: 0340-1855 Impact factor: 1.372